You are here
AdvaMed Statement on Commerce Competitiveness Report
WASHINGTON, D.C. – David Nexon, senior executive vice president of the Advanced Medical Technology Association (AdvaMed), issued the following statement in reaction to the U.S. Commerce Department’s “America Competes” report:
“Today’s report is another encouraging sign that Congress and the Administration recognize the importance of policy changes to keep and enhance American competitiveness. The report makes a strong case for the need to have a national focus on innovation and competiveness to secure America’s future prosperity, and it highlights some important policy challenges needed if America is to continue to be the global economic leader.
“The medical technology industry is an important example in this policy discussion. America is the acknowledged world leader in our industry, which is an important generator of jobs and economic growth. But American leadership today is challenged and will not be maintained without good government policies.
“The report’s strong emphasis on the need to focus on manufacturing is heartening. We also support the need, highlighted in the report, for more research and development; improvements in science, technology, engineering and mathematics education; fair trade policies; and to make innovation a top priority for both government and industry.
“Regulatory and corporate tax policies, though not covered in detail in the report, are also critical to the future competiveness of medical technology and other industries. We cannot be competitive unless regulation supports innovation at the same time it protects public health and safety. Also, American corporate taxes are much higher than those of other nations and our tax structure does not support industries that are engaged in international competition. Unless tax policy is revised to create a more level international playing field, America will be competing with one hand behind its back in the race to grow valuable, good-paying jobs.
“We believe today’s report will help foster an increased focus in Washington on the need for public policy to more effectively support innovation and competitiveness, a focus AdvaMed began calling for last year in our Competitiveness Agenda.
“We also commend the Commerce Department for soliciting the views of an important leader in the medical technology industry, Welch Allyn CEO and President Julie Shimer, in compiling the report.”
AdvaMed member companies produce the medical devices, diagnostic products and health information systems that are transforming health care through earlier disease detection, less invasive procedures and more effective treatments. AdvaMed members range from the largest to the smallest medical technology innovators and companies.